{"timestamp": 1771609131.6922917, "value": {"ticker": "ENLV", "company_name": "Enlivex Therapeutics Ltd.", "short_name": "Enlivex Therapeutics Ltd.", "sector": "Healthcare", "industry": "Biotechnology", "country": "Israel", "market_cap": 240942224, "float_shares": 6281155, "shares_outstanding": 237381498, "short_ratio": 1.1, "short_percent_of_float": 0.0022, "shares_short": 526156, "shares_short_prior": 603238, "insider_percent_held": 0.00463, "institution_percent_held": 0.00801, "total_cash": 18203000, "total_debt": 701000, "total_revenue": 0, "revenue_growth": 0, "earnings_growth": 0, "profit_margins": 0.0, "gross_margins": 0.0, "operating_margins": 0.0, "debt_to_equity": 4.01, "current_ratio": 6.433, "book_value": 0.72, "price_to_book": 1.4097221, "operating_cashflow": -11874000, "free_cashflow": -5533500, "price": 1.015, "52w_high": 2.1, "52w_low": 0.66, "avg_volume": 4180535, "avg_volume_10d": 371670, "full_time_employees": 0, "audit_risk": 0, "overall_risk": 0}}